Esmolol Infusion Rate Calculator | mcg/kg/min to mL/hr

Patient Weight (kg)

Bag Strength milligrams per mL

Total Esmolol (mg) buttons step by 10 mg; type any value

Total Final Volume (mL)

ⓘ Locally diluted bags are the documented route to a fatal esmolol overdose. The label records that massive accidental overdoses “have resulted from dilution errors”, that some were fatal and others left permanent disability, and that bolus doses of 625 mg to 2.5 g have been fatal — and that the premixed bags may reduce that risk. Prefer a preset container above; use this panel only where local practice requires it, and have a second person check the total against the volume.

Patient Weight

— kg

Bag Strength

— mg/mL

Step-Wise Dosing Reference Table

Dose (mcg/kg/min)	Equivalent (mg/hr)	Pump Rate (mL/hr)	24-h Total
Enter patient weight to generate rates.

ⓘ The badges mark only where to start and where the label stops. The rungs between them are the label’s own titration path — 50 → 100 → 150 → 200 mcg/kg/min at intervals of at least 4 minutes — and the 25 row is there because the label notes doses that low have been adequate. Most patients never reach the last row: in the label’s trials about 95% of responders did so at 200 mcg/kg/min or less and the average effective dose was about 100 mcg/kg/min. The red badge is a ceiling, not a prohibition — above it the label says the added heart-rate lowering is little while adverse reactions increase. The exception is hypertension, for which it allows 250–300 mcg/kg/min; safety above 300 has not been studied.

Typical Titration Dose Range

Usual Dose Range: 50 – 200 mcg/kg/min (effective maintenance range)

50mcg/kg/min

100

150

200mcg/kg/min

Low

Medium

High

Loading dose — gradual control / SVT (500 mcg/kg over 1 minute, optional)

— mg

Enter patient weight.

Loading dose — immediate perioperative control (1 mg/kg over 30 seconds)

— mg

Enter patient weight.

Confirm the bag is mg/mL, not mcg/mL — 10 mg/mL is 10,000 mcg/mL. Hypotension can occur at any dose and is dose-related; the label caps rate control at 200 mcg/kg/min. Esmolol is contraindicated in severe sinus bradycardia, heart block greater than first degree, sick sinus syndrome, decompensated heart failure, cardiogenic shock, pulmonary hypertension, known hypersensitivity to esmolol or any inactive ingredient (including anaphylaxis; cross-sensitivity between beta blockers is possible), and in close proximity to IV verapamil-type calcium-channel blockers. Avoid infusions into small veins or through a butterfly catheter — infusion-site reactions were the third most common adverse reaction in the label’s trials (8%), and severe reactions include thrombophlebitis, necrosis and blistering, particularly with extravasation. Titrate no faster than every 4 minutes and check the rhythm and blood pressure at each step.

Show calculation steps

Recent Updates

The ASHP Standardize 4 Safety adult standards, updated June 2026, list esmolol at 10 and 20 mg/mL with a dosing unit of mcg/kg/min — and flag it as one of the entries whose dosing unit differs from its concentration unit.
A 2025 Chest meta-analysis of 8 randomized trials (885 patients) found ultra-short-acting beta-blockers did not significantly reduce mortality in sepsis with persistent tachycardia (RR 0.84, 95% CI 0.68–1.02), tempering the single-center 2013 trial that first drew attention to the strategy.

Sources: American Society of Health-System Pharmacists. Standardize 4 Safety — Adult Continuous Infusion Standards, updated June 2026 · Sato R, et al. Chest 2025;167(1):121-138.

Key Knowledge Points

The ladder in this table is the label’s own. Brevibloc’s step-wise table moves 50 → 100 → 150 → 200 mcg/kg/min with at least 4 minutes between steps; the row at 25 is included because the label notes doses that low have been adequate.
Do not use esmolol to control tachycardia in a patient already receiving epinephrine, norepinephrine or dopamine. The label names those three: because of the risk of reducing cardiac contractility in the presence of high systemic vascular resistance, it directs that esmolol not be used for rate control in patients on drugs that are vasoconstrictive and positively inotropic — precisely the common ICU picture of a tachycardic patient already on a pressor.
If the pressure falls, cut the rate first — but do not withhold volume. Reducing or stopping the infusion reverses hypotension, usually within 30 minutes, and stopping is the label’s first step in managing toxicity. For symptomatic hypotension it then directs clinicians to consider intravenous fluids or a vasopressor — rescue after esmolol is stopped, not a license to run the two together. In hypovolemic patients esmolol also blunts reflex tachycardia and increases the risk of hypotension.
Check what else is running in the line. Esmolol is not compatible with 5% sodium bicarbonate (limited stability) or furosemide (precipitation) — and furosemide is often given to the same patient in the same hour. It was tested against the common crystalloid and dextrose solutions at 10 mg/mL and found stable for at least 24 hours.
A 9-minute half-life is the reason to choose it. Hypotension usually reverses within 30 minutes of reducing or stopping the infusion, and stopping the infusion is the label’s first step in managing toxicity — but the same short action means an interrupted line loses control quickly.

About This Esmolol Infusion Rate Calculator

This Esmolol Infusion Rate Calculator converts an esmolol order in mcg/kg/min into a pump rate in mL/hr, and also shows the mg/hr and 24-hour totals that many charts record. The presets are the two ready-to-use strengths in the FDA label and the ASHP Standardize 4 Safety table: 10 mg/mL, supplied as the 2500 mg / 250 mL premixed bag, and 20 mg/mL, the 2000 mg / 100 mL double-strength bag. The label also supplies a 100 mg / 10 mL ready-to-use vial, but for giving a loading dose by hand-held syringe while the infusion is prepared rather than for the infusion itself. Custom mode covers locally prepared bags.

The Formulas Explained

Dose (mg/hr) = Dose (mcg/kg/min) × Weight (kg) × 60 ÷ 1000
Rate (mL/hr) = Dose (mg/hr) ÷ Bag Strength (mg/mL)

The division by 1000 is the step that matters: the order is in micrograms and the bag is in milligrams. A 70 kg adult at 100 mcg/kg/min receives 7000 mcg/min, which is 420 mg/hr and runs at 42.0 mL/hr from a 10 mg/mL bag — or 21.0 mL/hr from the 20 mg/mL double-strength bag. The loading dose is a weight-based amount rather than a rate: 500 mcg/kg is 35 mg in the same patient, given over one minute.

Clinical Interpretation & Limitations

Esmolol is a cardioselective beta-1 blocker with an elimination half-life of about 9 minutes. That is its whole point: beta-blockade can be started in a patient who might not tolerate it, and withdrawn within minutes if they do not. The label’s own indications are supraventricular tachycardia or non-compensatory sinus tachycardia, and perioperative tachycardia and hypertension.

Hypotension is the dose-limiting effect, not bradycardia. It leads the label’s adverse-reaction table: asymptomatic hypotension 25%, symptomatic hypotension 12% (hyperhidrosis, dizziness). The footnote is the part worth carrying to the bedside — hypotension resolved during the infusion in 63% of patients, and in 80% of the remainder within 30 minutes of stopping. Most episodes settle without stopping the drug at all. Because the effect is dose-related the first move is to cut the rate; the label then directs that symptomatic hypotension be supported with intravenous fluids or a vasopressor, so volume is not to be withheld.

Beyond the labeled indications

Rate control in atrial fibrillation or flutter is a labeled indication, not an off-label one. Section 1.1 indicates esmolol for rapid control of ventricular rate in atrial fibrillation or flutter in perioperative, postoperative or other emergent circumstances. The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline lists it for acute rate control at 500 mcg/kg over 1 minute, then 50–300 mcg/kg/min — an upper figure that exceeds the label’s own 200 mcg/kg/min rate-control ceiling.

The genuinely off-label use is heart-rate control in septic shock. The 2013 single-center open-label trial reported 28-day mortality of 49.4% with esmolol versus 80.5% with standard care, but the control-arm mortality was extreme and the design was phase 2. A 2025 meta-analysis of 8 randomized trials found no significant mortality reduction (RR 0.84, 95% CI 0.68–1.02) and called its own result not robust. There is also a labeling conflict: most of these patients are on norepinephrine, which the label names among the agents that should preclude using esmolol for rate control. Treat it as unsettled; this ladder is the label’s, not a sepsis protocol.

Limitations

Adults only. Pediatric pharmacokinetics differ — a shorter half-life and higher clearance in newborns and infants, and reported post-coarctectomy requirements averaging around 700 mcg/kg/min, well outside this table.
The color bands are label ranges, not outcome-validated targets. No trial ties a band to survival.
The label limits maintenance infusions to up to 48 hours; longer courses are outside its evidence.
“No dosage adjustment needed” is narrower than it sounds. Esmolol is hydrolysed by red-cell esterases and the label requires no adjustment in hepatic impairment, but its renal statement is bounded: no adjustment for a maintenance infusion of 150 mcg/kg over 4 hours, with no information on rates above 150 mcg/kg or infusions longer than 4 hours. The renally cleared acid metabolite has a half-life about 12-fold longer in end-stage renal disease, and the label warns of potentially life-threatening hyperkalemia in hemodialysis patients.
Weight entry stops at 199 kg, the house limit across these calculators.

Frequently Asked Questions (FAQ)

1. What rate does an esmolol infusion run at?

The FDA label’s step-wise table starts maintenance at 50 mcg/kg/min and moves through 100, 150 and 200 mcg/kg/min, titrating at intervals of at least 4 minutes. The effective maintenance range is 50 to 200 mcg/kg/min, although the label notes doses as low as 25 mcg/kg/min have been adequate. At 70 kg on a 10 mg/mL bag, 100 mcg/kg/min is 42 mL/hr.

2. Is the esmolol loading dose required?

No. The label calls it optional and states that without loading doses a continuous infusion reaches steady state in about 30 minutes. For gradual control it is 500 mcg/kg over one minute; for immediate perioperative control the label instead gives 1 mg/kg over 30 seconds followed by 150 mcg/kg/min. Additional loading doses may be repeated between steps.

3. Why is the esmolol bag labeled in mg/mL when the order is in mcg/kg/min?

Because esmolol is one of the few infusions where the concentration unit and the dosing unit differ, which the ASHP Standardize 4 Safety table flags explicitly. A 10 mg/mL bag is 10,000 mcg/mL, so a bag read as 10 mcg/mL would be a thousandfold error. Confirm the bag strength before programming, and remember 1 mg is 1000 mcg.

4. Can esmolol be run above 200 mcg/kg/min?

Not for rate control. The label states that maintenance doses above 200 mcg/kg/min are not recommended because they provide little additional heart-rate lowering and adverse reactions increase. For hypertension the label allows 250 to 300 mcg/kg/min, and states the safety of doses above 300 mcg/kg/min has not been studied.

5. How quickly does esmolol wear off after it is stopped?

Its elimination half-life is approximately 9 minutes, which is why it is chosen when beta-blockade may need to be withdrawn quickly. The label states hypotension usually reverses within 30 minutes of reducing or stopping the infusion, and that stopping the infusion is the first step in managing toxicity.

Related Calculators

Before switching between these agents, read the label’s two constraints. Esmolol is contraindicated with intravenous cardiodepressant calcium-channel antagonists given in close proximity — while the cardiac effects of the other are still present — and the label records fatal cardiac arrests with esmolol plus intravenous verapamil. When transitioning, it sets a specific taper: thirty minutes after the first dose of the alternative drug, halve the esmolol infusion rate, then stop it after the second dose if control holds for an hour.

📖 Sources:

📝 How to cite this page:

DosePilot Medical Team. Esmolol Infusion Rate Calculator. DosePilot. Published August 16, 2026. Last medically reviewed August 2026. https://dosepilot.com/calc/esmolol-infusion-rate-calculator/

⚠️ Disclaimer:

This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. Esmolol concentrations and titration protocols vary between institutions — always follow the approved product information and local policy. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.